INTRODUCTION
Sphingomyelinase (sphingomyelin phosphorylcholine phosphohydrolase) (EC 3.1.4.12) hydrolyzes sphingomyelin to ceramide and phosphorylcholine. A lysosomal form of the enzyme requires no known cofactors (1) (2) (3) . The lysosomal sphingomyelinase is absent or reduced in some forms of the hereditary disorder Niemann-Pick disease, resulting in excessive sphingomyelin storage in the tissues (4) . Mammalian tissues also contain two forms of sphingomyelinase with Receivedfor publication 7 (3, 5, 6) , while the other does not (7) .
Some sphingolipid hydrolases lose activity toward their natural substrates upon purification. Activity can be restored by small glycoproteins from lysosomes or from heated extracts oftissues (8) (9) (10) (11) . These small proteins have been referred to as activators and may combine with sphingolipids to form complexes (12) , which are more suitable substrates for the sphingolipid hydrolases. There is evidence that these activator proteins may facilitate the hydrolysis of sphingolipids in vivo (8) . In the case of sphingomyelinase, effects of activator proteins have been reported (9, 11) . In many instances, sphingolipid hydrolase activity can be promoted by a detergent in the absence of an activator protein. Triton X-100 is widely used for demonstration of sphingomyelinase activity. This detergent forms a mixed micelle with sphingomyelin (13) .
Sphingomyelin is an important constituent of membranes. It is transported through the blood as an integral component oflipoproteins (14) that can be taken up by the cells in various tissues. Koenig (15) found that a large partion of lysosomal protein consists of lipoproteins. These studies examine the interaction of various plasma apolipoproteins with lysosomal sphingomyelinase. The in vitro results raise the possibility that apolipoprotein C-III-1 (apoC-III-1)1 may function as an activator of lysosomal sphingomyelinase in vivo. The effect of the abundant phospholipid, phosphatidylcholine, was also examined. In addition, the effect of the natural detergent lysophosphatidylcholine (LPC) was studied, since it might be produced in the lysosome as a product of lipoprotein metabolism. (17) , and the C group (18) were prepared with published methods. ApoA-I was in 50 mM borate, pH 8.0. The other apolipoproteins were in 100 mM NaCl, 10 mM Tris-Cl, 1 mM EDTA, 1 mM NaN3, pH 7.4 (buffer A). In addition, the apoC-III-1 solution contained 0.5 M guanidiniuim hydrochloride. These variations in salts and buffers were determined to have minimal effect on sphingomyelinase activity under the conditions used. Apolipoprotein solutions were diluted as needed into buffer A immediately before use. The components ofthe apoC mixture were assumed to have an average molecular weight of 8700.
METHODS
A 2 mM phosphatidylcholine suspension was prepared in water as described below for sphingomyelin.
Preparation of extracts. Human skin fibroblasts were cultured as described previously (19) . 10 d after cells achieved confluence they were washed three times with 0.9% saline, and the cells from a 150-mm plate were scraped in 0.8 ml of deionized water. The cells were disrupted by sonication for two intervals of 15 s using a Branson sonifier (Branson Sonic Power Co., Danbury, Conn.) set to an output of 30 W. The mixture was centrifuged at 1,000g for 10 min and the supernatant (1.3-1.7 mg protein/ml) used for enzyme assay.
Enzyme assays. Protein was measured according to Lowry et al. (20) , using bovine serum albumin as standard.
Radioactive sphingomyelin was mixed with unlabeled sphingomyelin in toluene: methanol 1:1 to give a 6 mM stock solution with a 0.87 mCi/mmol sp act. For the preparation of substrate solution, the solvent was evaporated from an aliquot of stock solution with a stream of N2. The substrate was suspended in 0.2 M sodium acetate to give a concentration of 0.6 mM and the mixture heated at 500C for 3 min, with vigorous vortex mixing. The assay reaction volume was 0.1 ml with the following final concentrations: 0.1 M sodium acetate (pH 4.0 or as indicated) and 0.30 mM (or less as noted) [14C] sphingomyelin. Reactions were started by the addition of 10 ,p of fibroblast extract. Samples were mixed vigorously at this time and again after 3-h incubation at 37°C. The time of incubation was 6 h unless indicated otherwise; the rate was linear up to 24 h. Reactions were stopped by the sequential addition of 1.0 ml cold 1% bovine serum albumin solution, 0.3 ml of 50% TCA, and 0.1 ml of cold 10% bovine serum albumin solution. The mixture was centrifuged 10 min at 1000g. 1 ml of the supernatant was added to 9.0 ml Aquasol (New England Nuclear) and the released [14C] phosphorylcholine was quantitated in a Beckman LS-3133T Scintillation Counter (Beckman Instruments, Fullerton, Calif.). Additive FIGURE 1 Effect of apolipoproteins, LPC, and Triton X-100 on lysosomal sphingomyelinase activity. Assays were conducted as described in Methods, using 3.9 ,ug ofextract protein with Triton X-100 or 13 ,ug with all other additives. The additives present were: O, none; 0, apoA-I; 0, apoA-II; *, apoC mixture; A, LPC; A, Triton X-100.
70 ,uM stimulated the reaction 20-fold. An apoC mixture stimulated activity sixfold at a concentration of4.5 AM. was present in a concentration range of 2 AM to 0.8 mM. Triton X-100 stimulated sphingomyelinase activity 300-fold. The optimal concentration for Triton X-100 was 0.5 mM with a sphingomyelin to Triton X-100 molar ratio of 0.6, thus requiring a much higher concentration than for the natural additives. The reaction rate was still 70% of the maximum when the concentration ofTriton X-100 was 10 times greater than the optimal concentration. Fig. 2 shows the effects of individual components of the apoC mixture on sphingomyelinase activity. The optimum concentration for stimulation by apoC-III-1 was 5 ,tM, which was in the same range as for the apoC mixture. ApoC-III-1 was more effective, with a 14-fold stimulation observed. ApoC-I was a poor stimulator and was an inhibitor at high concentration. ApoC-II conferred modest stimulation, and then only when present at high concentration. The reaction rate was minimal when apoC-III-1 was present at 10 times the optimal concentration.
The pH optimum of sphingomyelinase was 4.0 when stimulated by apoA-II, apoC-III-1, or LPC (Fig. 3) sphingomyelinase-deficient fibroblasts was used. This result, with the pH optimum data, indicated that the lysosomal sphingomyelinase was the activated enzyme.
The concentration of LPC that conferred maximal activation was dependent on the concentration of the substrate (Fig. 4) . A 10-fold decrease in the concentration of sphingomyelin produced a twofold decrease in the optimal concentration of LPC. By contrast, the optimal concentration of apoC mix was independent of sphingomyelin concentration over this range.
DISCUSSION We have observed a clear activation of lysosomal sphingomyelinase by apoC-III-1 in vitro. It remains to be determined whether or not this is a significant phenomenon in the intact organism. Up to the present, attention has focused on the role of apolipoproteins in the extracellular space. ApoA-I and apoC-I activate lecithin-cholesterol acyltransferase (21) . ApoC-II activates lipoprotein lipase, and this activation is antagonized by apoA-I, A-II, C-I, C-III, E, and excess C-Il (22, 23) . Lipoproteins are taken up by cells, and apoE enhances uptake while apoC-III-1 antagonizes this effect (24, 25) . Low density lipoproteins, taken into the cell, enter the lysosome specifically (26) (29) . The question remains whether or not the activation of sphingomyelinase by apoC-III-1 is physiologically significant. The occurrence of the AB variant of GM2 gangliosidosis due to deficiency of an activator protein (8) argues strongly that some in vitro activators are important in the organism, as does the occurrence of hypertriglyceridemia due to apoC-II deficiency and the consequent effect on lipoprotein lipase (30) . The fact that apoC-III-1 activates sphingomyelinase, while other apolipoproteins do not, might favor a functional significance for the activity. These observations raise the possibility that lysosomal activators might not simply arise endogenously in the cell, but also could originate outside the cell in the process of metabolic turnover. Plasma apolipoproteins would form one such class of activators. Another might be proteins that form complexes with lipids in the brain. Such activator proteins could play a role in targeting lipoprotein complexes to the lysosome and/or in the activation of lysosomal hydrolases. Finally, our observations raise the possibility that some forms of sphingomyelin lipidosis that exhibit normal sphingomyelinase activity in vitro might be due to abnormalities in an activator protein such as apoC-IJI.
